Cambrex invests in generic API development and manufacturing capabilities at its Milan site. Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), announced that it has made a number of investments, in both R&D and manufacturing capabilities to support the development and production of generic APIs, at its site…